| Name | Title | Contact Details |
|---|
At Magellan Health, we have a unique vision of better and more affordable care in the fast growing, highly complex and high cost areas of health care. Our complete-person perspective helps us deliver better outcomes and brighter futures. Magellan Health, Inc. is a health care management company headquartered in Scottsdale, AZ. The depth and breadth of our experience in managing behavioral health care, diagnostic imaging, specialty pharmaceutical services and in providing pharmacy benefits administration enable us to deliver inspired insights and innovative solutions that positively impact both the quality and the cost of some of the nation`s fastest growing areas of health care. Magellan is proud to be a founding member of Hero Health Hire, a coalition of health care companies committed to recruiting, hiring and training veterans, wounded warriors and military spouses.
Portamedic is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioRealty, Inc. is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.